Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michèle Sorgenfrei

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|April 29, 2022
Biomolecules capturing live bacteria from clinical samplesMichèle Sorgenfrei, Lea M Hürlimann, Mélissa M Remy, et al.
Nature Chemical Biology|January 17, 2024
Profiling the interactome of oligonucleotide drugs by proximity biotinylationAlfred Hanswillemenke, Daniel Tobias Hofacker, Michèle Sorgenfrei, et al.
Trends in Biochemical Sciences|January 20, 2023
Creating overview and summary figuresMeg Critcher, Lara A Gruijs da Silva, Dorothee Dormann, et al.
Nature Communications|January 9, 2024
Doa10/MARCH6 architecture interconnects E3 ligase activity with lipid-binding transmembrane channel to regulate SQLEJ Josephine Botsch, Roswitha Junker, Michèle Sorgenfrei, et al.
Communications Biology|July 14, 2025
Rapid detection and capture of clinical Escherichia coli strains mediated by OmpA-targeting nanobodiesMichèle Sorgenfrei, Lea M Hürlimann, Andrea Printz, et al.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
EMBO Reports|March 7, 2022
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistanceJustin D Walter, Melanie Scherer, Cedric A J Hutter, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|April 29, 2022
Biomolecules capturing live bacteria from clinical samplesMichèle Sorgenfrei, Lea M Hürlimann, Mélissa M Remy, et al.
Nature Chemical Biology|January 17, 2024
Profiling the interactome of oligonucleotide drugs by proximity biotinylationAlfred Hanswillemenke, Daniel Tobias Hofacker, Michèle Sorgenfrei, et al.
Trends in Biochemical Sciences|January 20, 2023
Creating overview and summary figuresMeg Critcher, Lara A Gruijs da Silva, Dorothee Dormann, et al.
Nature Communications|January 9, 2024
Doa10/MARCH6 architecture interconnects E3 ligase activity with lipid-binding transmembrane channel to regulate SQLEJ Josephine Botsch, Roswitha Junker, Michèle Sorgenfrei, et al.
Communications Biology|July 14, 2025
Rapid detection and capture of clinical Escherichia coli strains mediated by OmpA-targeting nanobodiesMichèle Sorgenfrei, Lea M Hürlimann, Andrea Printz, et al.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
EMBO Reports|March 7, 2022
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistanceJustin D Walter, Melanie Scherer, Cedric A J Hutter, et al.
Pageof 1